Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Russian lender Credit Bank of Moscow (CBM) raised Rb14.4bn ($250m) of fresh equity with a 13.4% capital increase this week. -
Hutchison China MediTech hit the market on Wednesday with a view to raising around $262m from a follow-on sale of American depository shares (ADS), according to a term sheet seen by GlobalCapital Asia.
-
Deutsche Bank is tonight leading a block trade so that three foundations that are among the largest shareholders in Liberbank can 'tail-swallow', meaning sell some of their stakes to finance subscription to Liberbank's €500m rights issue.
-
Ablynx, the Belgian biopharmaceutical firm, has raised $200m through a second listing in the US, following positive momentum in the development of a new drug designed to combat a life-threatening blood clotting disorder.
-
CapitaLand Commercial Trust (CCT) has raised S$700m ($514.7m) from a rights issue after a flood of excess applications pushed the deal to nearly twice subscribed.
-
Hong Kong-listed 13 Holdings is planning a rights issue of up to HK$1.15bn ($147.8m) to help restart the development of its luxury Macau destination, The 13 Hotel.
